Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kamil ZS"'
Autor:
Nag A; Ocular Oncology Service, Department of Ophthalmology and Visual Sciences, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, ON, Canada., Krema H; Ocular Oncology Service, Department of Ophthalmology and Visual Sciences, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, ON, Canada., Kamil ZS; Department of Diagnostic and Molecular Pathology, University of Toronto, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada., Al-Mbaideen S; Department of Diagnostic and Molecular Pathology, University of Toronto, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada.
Publikováno v:
Case reports in oncology [Case Rep Oncol] 2024 Jul 10; Vol. 17 (1), pp. 712-716. Date of Electronic Publication: 2024 Jul 10 (Print Publication: 2024).
Autor:
Dent A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada., Faust K; Department of Computer Science, University of Toronto, 40 St. George Street, Toronto, ON M5S 2E4, Canada.; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada., Lam KHB; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada.; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Alhangari N; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada., Leon AJ; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada., Tsang Q; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada., Kamil ZS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Laboratory Medicine Program, Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada., Gao A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Laboratory Medicine Program, Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada., Pal P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Laboratory Medicine Program, Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada., Lheureux S; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada., Oza A; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada., Diamandis P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Princess Margaret Cancer Centre, 101 College Street, Toronto, ON M5G 1L7, Canada.; Laboratory Medicine Program, Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.; Department of Medical Biophysics, University of Toronto, 101 College St, Toronto, ON M5G 1L7, Canada.
Publikováno v:
Science advances [Sci Adv] 2023 Sep 29; Vol. 9 (39), pp. eadg1894. Date of Electronic Publication: 2023 Sep 29.
Autor:
Fournier C; Princess Margaret Cancer Center, Toronto, Ontario, Canada.; Division of Dematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Sauder MB; Princess Margaret Cancer Center, Toronto, Ontario, Canada.; Division of Dematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Kamil ZS; Toronto General Hospital, Toronto, Ontario, Canada.; Department of Laboratory Medicine & Pathobiology, Anatomic Pathology, University of Toronto, Toronto, Ontario, Canada., Butler MO; Princess Margaret Cancer Center, Toronto, Ontario, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2023 Jul 27; Vol. 39, pp. 145-149. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).
Autor:
Gonzalez-H Leon A; Ocular Oncology Service, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Chavez Y; Ocular Oncology Service, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Kamil ZS; Laboratory Medicine & Pathobiology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Ghazarian D; Laboratory Medicine & Pathobiology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Krema H; Ocular Oncology Service, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publikováno v:
Ophthalmic genetics [Ophthalmic Genet] 2022 Aug; Vol. 43 (4), pp. 518-521. Date of Electronic Publication: 2022 Mar 08.
Autor:
Hanout M; Princess Margaret Cancer Center/University Health Network, Ocular Oncology Service, Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, ON, Canada., Kamil ZS; Toronto General Hospital/University Health Network, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Alrjoub M; Toronto General Hospital/University Health Network, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Laperriere N; Princess Margaret Cancer Centre/University Health Network, Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Altomare F; Princess Margaret Cancer Center/University Health Network, Ocular Oncology Service, Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, ON, Canada.; St. Michael's Hospital, Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada., Krema H; Princess Margaret Cancer Center/University Health Network, Ocular Oncology Service, Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, ON, Canada.
Publikováno v:
European journal of ophthalmology [Eur J Ophthalmol] 2022 Jan; Vol. 32 (1), pp. NP1-NP4. Date of Electronic Publication: 2020 Jul 22.
Autor:
Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: thiago.muniz@uhn.ca., Sorotsky H; Institute of Oncology, Chaim Sheba Medical Center at Tel-Hashomer, Ramant Gan, Israel., Kanjanapan Y; Department of Medical Oncology, Canberra Region Cancer Centre, Canberra, Australia., Rose AAN; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada., Araujo DV; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto, Brazil., Fortuna A; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Ghazarian D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine & Pathobiology, University Health Network, University of Toronto, Toronto, Ontario, Canada., Kamil ZS; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine & Pathobiology, University Health Network, University of Toronto, Toronto, Ontario, Canada., Pugh T; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Mah M; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Trillium Health Partners, Genetics Laboratory, Mississauga, Ontario, Canada., Thiagarajah M; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Department of Laboratory Medicine, Unity Health Toronto, Toronto, Ontario, Canada., Torti D; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Phase 1 Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hogg D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2021 Oct; Vol. 141 (10), pp. 2470-2479. Date of Electronic Publication: 2021 Apr 06.
Autor:
Kamil ZS; Drs. Kamil and Ghazarian and Mr. Sachdeva are from the University of Toronto, Ontario, Canada. Drs. Kamil and Ghazarian are from the Department of Laboratory Medicine and Pathobiology. Drs. Kamil and Ghazarian also are from the Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto. Dr. Kwapis is from Sensenbrenner Hospital, Kapuskasing, Ontario, and McMaster University, Hamilton, Ontario., Sachdeva M; Drs. Kamil and Ghazarian and Mr. Sachdeva are from the University of Toronto, Ontario, Canada. Drs. Kamil and Ghazarian are from the Department of Laboratory Medicine and Pathobiology. Drs. Kamil and Ghazarian also are from the Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto. Dr. Kwapis is from Sensenbrenner Hospital, Kapuskasing, Ontario, and McMaster University, Hamilton, Ontario., Kwapis J; Drs. Kamil and Ghazarian and Mr. Sachdeva are from the University of Toronto, Ontario, Canada. Drs. Kamil and Ghazarian are from the Department of Laboratory Medicine and Pathobiology. Drs. Kamil and Ghazarian also are from the Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto. Dr. Kwapis is from Sensenbrenner Hospital, Kapuskasing, Ontario, and McMaster University, Hamilton, Ontario., Ghazarian D; Drs. Kamil and Ghazarian and Mr. Sachdeva are from the University of Toronto, Ontario, Canada. Drs. Kamil and Ghazarian are from the Department of Laboratory Medicine and Pathobiology. Drs. Kamil and Ghazarian also are from the Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto. Dr. Kwapis is from Sensenbrenner Hospital, Kapuskasing, Ontario, and McMaster University, Hamilton, Ontario.
Publikováno v:
Cutis [Cutis] 2021 Oct; Vol. 108 (4), pp. E24-E28.
Autor:
Kelly D; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada., Rose AAN; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Department of Oncology, McGill University, Montreal, QC H3A1G5, Canada.; Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T1E2, Canada., Muniz TP; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada., Hogg D; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada., Butler MO; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., Saibil SD; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., King I; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G1Z5, Canada., Kamil ZS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G1Z5, Canada., Ghazarian D; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G1Z5, Canada., Ross K; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., Iafolla M; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., Araujo DV; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto 15090-000, SP, Brazil., Waldron J; Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON M5G1Z5, Canada., Laperriere N; Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON M5G1Z5, Canada., Krema H; Princess Margaret Cancer Centre, Ocular Oncology Service Krembil Research Institute, University Health Network, Toronto, ON M5G2C1, Canada., Spreafico A; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jul 20; Vol. 13 (14). Date of Electronic Publication: 2021 Jul 20.
Autor:
Kim N; Department of Medicine, University of Toronto, Toronto, Canada., Kashetsky N; Faculty of Medicine, Memorial University of Newfoundland, St. John's, Canada., Velykoredko Y; University Health Network, Toronto, Canada., Murray M; Mater Misericordiae University Hospital, Dublin, Ireland., Singer L; Department of Medicine, University of Toronto, Toronto, Canada.; University Health Network, Toronto, Canada., Kamil ZS; University Health Network, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Ghazarian D; University Health Network, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Chan AW; Department of Medicine, University of Toronto, Toronto, Canada.; University Health Network, Toronto, Canada.; Women's College Research Institute, Toronto, Canada.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2021 May 14; Vol. 13, pp. 62-64. Date of Electronic Publication: 2021 May 14 (Print Publication: 2021).
Autor:
Rose AAN; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada april.rose@mail.mcgill.ca Anna.Spreafico@uhn.ca.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada., Armstrong SM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Hogg D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Saibil SD; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Arteaga DP; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada., Pimentel Muniz T; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada., Kelly D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada., Ghazarian D; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., King I; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kamil ZS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ross K; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Spreafico A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada april.rose@mail.mcgill.ca Anna.Spreafico@uhn.ca.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jan; Vol. 9 (1).